Iradimed (IRMD) EBT (2013 - 2026)

Iradimed (IRMD) has reported EBT for 14 consecutive years, with $6.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT fell 5.99% year-over-year to $6.9 million in Q2 2026; TTM through Jun 2026 was $29.7 million, a 14.25% increase from a year earlier, with the FY2025 full-year figure at $28.4 million, up 16.83% from the prior year.
• EBT was $6.9 million for Q2 2026 at Iradimed, down from $7.8 million in the prior quarter.
• Over five years, EBT peaked at $7.8 million in Q4 2025 and troughed at $3.1 million in Q1 2022.
• A 5-year average of $5.8 million and a median of $6.1 million in 2024 frame the typical range for EBT.
• Across the five-year window, EBT jumped 125.03% in 2022 and slipped 5.99% in 2026, its largest moves.
• Over 5 years, EBT stood at $4.7 million in 2022, then climbed by 20.79% to $5.7 million in 2023, then gained by 11.66% to $6.3 million in 2024, then increased by 22.8% to $7.8 million in 2025, then decreased by 11.59% to $6.9 million in 2026.
• The last three EBT figures came in at $6.9 million (Q2 2026), $7.8 million (Q1 2026), and $7.8 million (Q4 2025), per Business Quant data.